Raman spectroscopy in chronic heart failure diagnosis based on human skin analysis.

This work aims at studying Raman spectroscopy in combination with chemometrics as an alternative fast noninvasive method to detect chronic heart failure (CHF) cases. Optical analysis is focused on the changes in the spectral features associated with the biochemical composition changes of skin tissues. A portable spectroscopy setup with the 785 nm excitation wavelength was used to record skin Raman features. In this in vivo study, 127 patients and 57 healthy volunteers were involved in measuring skin spectral features by Raman spectroscopy. The spectral data were analyzed with a projection on the latent structures and discriminant analysis. 202 skin spectra of patients with CHF and 90 skin spectra of healthy volunteers were classified with 0.888 ROC AUC for the 10-fold cross validated algorithm. To identify CHF cases, the performance of the proposed classifier was verified by means of a new test set that is equal to 0.917 ROC AUC.

Classification of skin cancer using convolutional neural networks analysis of Raman spectra.

BACKGROUND AND OBJECTIVE: Skin cancer is the most common malignancy in whites accounting for about one third of all cancers diagnosed per year. Portable Raman spectroscopy setups for skin cancer "optical biopsy" are utilized to detect tumors based on their spectral features caused by the comparative presence of different chemical components. However, low signal-to-noise ratio in such systems may prevent accurate tumors classification. Thus, there is a challenge to develop methods for efficient skin tumors classification. METHODS: We compare the performance of convolutional neural networks and the projection on latent structures with discriminant analysis for discriminating skin cancer using the analysis of Raman spectra with a high autofluorescence background stimulated by a 785 nm laser. We have registered the spectra of 617 cases of skin neoplasms (615 patients, 70 melanomas, 122 basal cell carcinomas, 12 squamous cell carcinomas and 413 benign tumors) in vivo with a portable Raman setup and created classification models both for convolutional neural networks and projection on latent structures approaches. To check the classification models stability, a 10-fold cross-validation was performed for all created models. To avoid models overfitting, the data was divided into a training set (80% of spectral dataset) and a test set (20% of spectral dataset). RESULTS: The results for different classification tasks demonstrate that the convolutional neural networks significantly (p<0.01) outperforms the projection on latent structures. For the convolutional neural networks implementation we obtained ROC AUCs of 0.96 (0.94 - 0.97; 95% CI), 0.90 (0.85-0.94; 95% CI), and 0.92 (0.87 - 0.97; 95% CI) for classifying a) malignant vs benign tumors, b) melanomas vs pigmented tumors and c) melanomas vs seborrheic keratosis respectively. CONCLUSIONS: The performance of the convolutional neural networks classification of skin tumors based on Raman spectra analysis is higher or comparable to the accuracy provided by trained dermatologists. The increased accuracy with the convolutional neural networks implementation is due to a more precise accounting of low intensity Raman bands in the intense autofluorescence background. The achieved high performance of skin tumors classifications with convolutional neural networks analysis opens a possibility for wide implementation of Raman setups in clinical setting.

Raman spectroscopy based diagnosis of dermatofibrosarcoma protuberans: Case report.

Dermatofibrosarcoma protuberans is a rare disease and this pathology provokes insufficient oncological alertness among clinicians. A possible way to increase the accuracy of early diagnosis of rare skin neoplasms is "optical biopsy" using Raman spectroscopy tissue response. This case report of a 32-year-old woman with a dermatofibrosarcoma protuberans demonstrates that Raman spectroscopy based "optical biopsy" can help to diagnose rare tumors.

In vivo diagnosis of skin cancer with a portable Raman spectroscopic device.

In this study, we performed in vivo diagnosis of skin cancer based on implementation of a portable low-cost spectroscopy setup combining analysis of Raman and autofluorescence spectra in the near-infrared region (800-915 nm). We studied 617 cases of skin neoplasms (615 patients, 70 melanomas, 122 basal cell carcinomas, 12 squamous cell carcinomas and 413 benign tumors) in vivo with a portable setup. The studies considered the patients examined by GPs in local clinics and directed to a specialized Oncology Dispensary with suspected skin cancer. Each sample was histologically examined after excisional biopsy. The spectra were classified with a projection on latent structures and discriminant analysis. To check the classification models stability, a 10-fold cross-validation was performed. We obtained ROC AUCs of 0.75 (0.71-0.79; 95% CI), 0.69 (0.63-0.76; 95% CI) and 0.81 (0.74-0.87; 95% CI) for classification of a) malignant and benign tumors, b) melanomas and pigmented tumors and c) melanomas and seborrhoeic keratosis, respectively. The positive and negative predictive values ranged from 20% to 52% and from 73% to 99%, respectively. The biopsy ratio varied from 0.92:1 to 4.08:1 (at sensitivity levels from 90% to 99%). The accuracy of automatic analysis with the proposed system is higher than the accuracy of GPs and trainees, and is comparable or less to the accuracy of trained dermatologists. The proposed approach may be combined with other optical techniques of skin lesion analysis, such as dermoscopy- and spectroscopy-based computer-assisted diagnosis systems to increase accuracy of neoplasms classification.

Raman spectroscopy of human skin for kidney failure detection.

The object of this paper is in vivo study of skin spectral-characteristics in patients with kidney failure by conventional Raman spectroscopy in near infrared region. The experimental dataset was subjected to discriminant analysis with the projection on latent structures (PLS-DA). Application of Raman spectroscopy to investigate the forearm skin in 85 adult patients with kidney failure (90 spectra) and 40 healthy adult volunteers (80 spectra) has yielded the accuracy of 0.96, sensitivity of 0.94 and specificity of 0.99 in terms of identifying the target subjects with kidney failure. The autofluorescence analysis in the near infrared region identified the patients with kidney failure among healthy volunteers of the same age group with specificity, sensitivity, and accuracy of 0.91, 0.84, and 0.88, respectively. When classifying subjects by the presence of kidney failure using the PLS-DA method, the most informative Raman spectral bands are 1315 to 1330, 1450 to 1460, 1700 to 1800 cm-1 . In general, the performed study demonstrates that for in vivo skin analysis, the conventional Raman spectroscopy can provide the basis for cost-effective and accurate detection of kidney failure and associated metabolic changes in the skin.

Use of Raman spectroscopy to screen diabetes mellitus with machine learning tools: comment.

This paper comments on the article "Use of Raman spectroscopy to screen diabetes mellitus with machine learning tools" by E. Guevara et al. The authors propose an optical method for noninvasive automated screening of type 2 diabetes mellitus. Despite the high performance of the proposed method, results shown by the authors may be ambiguous due to the overestimation of classification models for Raman spectral data analysis.

Portable spectroscopic system for in vivo skin neoplasms diagnostics by Raman and autofluorescence analysis.

The present paper studies the applicability of a portable cost-effective spectroscopic system for the optical screening of skin tumors. in vivo studies of Raman scattering and autofluorescence (AF) of skin tumors with the 785 nm excitation laser in the near-infrared region included malignant melanoma, basal cell carcinoma and various types of benign neoplasms. The efficiency of the portable system was evaluated by comparison with a highly sensitive spectroscopic system and with the diagnosis accuracy of a human oncologist. Partial least square analysis of Raman and AF spectra was performed; specificity and sensitivity of various skin oncological pathologies detection varied from 78.9% to 100%. Hundred percent accuracy of benign and malignant skin tumors differentiation is possible only with a combined analysis of Raman and AF signals.

Combined Raman and autofluorescence ex vivo diagnostics of skin cancer in near-infrared and visible regions.

The differentiation of skin melanomas and basal cell carcinomas (BCCs) was demonstrated based on combined analysis of Raman and autofluorescence spectra stimulated by visible and NIR lasers. It was ex vivo tested on 39 melanomas and 40 BCCs. Six spectroscopic criteria utilizing information about alteration of melanin, porphyrins, flavins, lipids, and collagen content in tumor with a comparison to healthy skin were proposed. The measured correlation between the proposed criteria makes it possible to define weakly correlated criteria groups for discriminant analysis and principal components analysis application. It was shown that the accuracy of cancerous tissues classification reaches 97.3% for a combined 6-criteria multimodal algorithm, while the accuracy determined separately for each modality does not exceed 79%. The combined 6-D method is a rapid and reliable tool for malignant skin detection and classification.